Showing results (41-50 of 2,468) with videos related to

Sort By:
Pageof 247
The Journal of Headache and Pain|July 11, 2019
Fluctuations of sensorimotor processing in migraine: a controlled longitudinal study of beta event related desynchronizationMartin Syvertsen Mykland, Marte Helene Bjørk, Marit Stjern, et al.
The Journal of Headache and Pain|March 14, 2022
Migraine susceptibility is modulated by food triggers and analgesic overuse via sulfotransferase inhibitionDoga Vuralli, Burak Arslan, Elif Topa, et al.
The Journal of Headache and Pain|April 19, 2022
Measuring dose-related efficacy of eptinezumab for migraine prevention: post hoc analysis of PROMISE-1 and PROMISE-2Rami Apelian, Lee Boyle, Joe Hirman, et al.
The Journal of Headache and Pain|October 14, 2021
Risk for ischemic stroke and coronary heart disease associated with migraine and migraine medication among older adultsEmily C McKinley, Christine L Lay, Robert S Rosenson, et al.
The Journal of Headache and Pain|October 1, 2021
Efficacy of galcanezumab in patients with migraine and history of failure to 3-4 preventive medication categories: subgroup analysis from CONQUER studyRose Okonkwo, Antje Tockhorn-Heidenreich, Chad Stroud, et al.
The Journal of Headache and Pain|January 30, 2022
Cranial autonomic symptoms: prevalence, phenotype and laterality in migraine and two potentially new symptomsNazia Karsan, Karthik Nagaraj, Peter J Goadsby
The Journal of Headache and Pain|January 30, 2022
The efficacy and safety of atogepant for the prophylactic treatment of migraine: evidence from randomized controlled trialsXinyu Tao, Zeya Yan, Jiahao Meng, et al.
The Journal of Headache and Pain|March 20, 2022
Comparing the relative and absolute effect of erenumab: is a 50% response enough? Results from the ESTEEMen studyRaffaele Ornello, Carlo Baraldi, Simona Guerzoni, et al.
The Journal of Headache and Pain|February 20, 2022
Post-traumatic headache after mild traumatic brain injury in a one-year follow up study - risk factors and return to workYvonn Kraemer, Kaisa Mäki, Ivan Marinkovic, et al.
The Journal of Headache and Pain|February 22, 2022
Dual action of the cannabinoid receptor 1 ligand arachidonyl-2'-chloroethylamide on calcitonin gene-related peptide releaseIsabella Mai Christiansen, Jacob C A Edvinsson, Philip V Reducha, et al.
Pageof 247